DS

Deepak Sood

Director Director DIN 08915452
DIN 08915452 First appointment Oct 2020 Primary industry Financial Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepak Sood

Data last updated:

Deepak Sood was a Director at Medbay India Private Limited (2020–2021) and Additional Director at Rx Capital Private Limited (from 2020). The companies operate in Financial Services.

DIN 08915452
Primary Designation Director
Industry Financial Services
First Appointment 17 Oct 2020
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medbay India Private Limited U74999DL2015PTC288081
Director17 Oct 20202015₹18.49 Cr (FY 2022)Under Liquidation
Rx Capital Private Limited U65929DL2020PTC362361
Additional Director19 Oct 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rx Capital Private Limited
Medbay India Private Limited
Premium access

Shareholding and investment profile for Deepak Sood

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Sood

Deepak Sood was first appointed on 17 Oct 2020 as Director at Medbay India Private Limited.

Deepak Sood held 2 earlier board appointments: Medbay India Private Limited (Director, 17 Oct 2020 to 01 Jan 2021); Rx Capital Private Limited (Additional Director, from 19 Oct 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available